Skip to main content
. 2021 Jun 17;22(2):890. doi: 10.3892/etm.2021.10322

Figure 2.

Figure 2

Effects of IL-6 and plasma from patients with UC on intestinal epithelial cell barrier injury. (A) TEER values and (B) permeability for fluorescein yellow of NCM640 cells treated with IL-6, plasma from patients with UC or UC plasma containing IL-6 antibody. *P<0.05 vs. NC group; #P<0.05 vs. plasma group. UC, ulcerative colitis; TEER, transepithelial electrical resistance; NC, negative control.